PerkinElmer (PKI - Free Report) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.
Analysts' growing optimism on the earnings prospects of this maker of scientific instruments is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. This insight is at the core of our stock rating tool -- the Zacks Rank.
The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.
For PerkinElmer, there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year.
The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:
12 Month EPS
Current-Quarter Estimate Revisions
For the current quarter, the company is expected to earn $1.20 per share, which is a change of +13.21% from the year-ago reported number.
The Zacks Consensus Estimate for PerkinElmer has increased 45.87% over the last 30 days, as two estimates have gone higher compared to no negative revisions.
Current-Year Estimate Revisions
The company is expected to earn $4.40 per share for the full year, which represents a change of +7.32% from the prior-year number.
In terms of estimate revisions, the trend for the current year also appears quite encouraging for PerkinElmer. Over the past month, four estimates have moved higher compared to no negative revisions, helping the consensus estimate increase 15.71%.
Favorable Zacks Rank
Thanks to promising estimate revisions, PerkinElmer currently carries a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.
While strong estimate revisions for PerkinElmer have attracted decent investments and pushed the stock 23.2% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away.